Madame Linh NGUYEN PHUONG / Docteur

Production scientifique

• Cell-Free DNA Fragmentome Dynamics as a Biomarker for Immune-Checkpoint Inhibition in Advanced Carcinoma
  2025
  Linh Nguyen Phuong, Frederic Fina, Romain Zakrajsek, Lucie Della-Negra, Laurent Greillier, Pascale Tomasini, Jean-Laurent Deville, Audrey Boutonnet, Frédéric Ginot, Jean-Charles Garcia, Sébastien Salas, Sébastien Benzekry
  https://inria.hal.science/hal-05241485v1
  
• Computational modeling for circulating cell-free DNA in clinical oncology
  JCO Clinical Cancer Informatics, 2025
  Linh Nguyen Phuong, Sébastien Salas, Sébastien Benzekry
  https://hal.science/hal-04481689v3
  
• Mechanistic Modeling of Joint Circulating Cell-free DNA ConcentrationTumor Size Kinetics under Immune-Checkpoint Inhibitors in Advanced Cancer
  2025
  Linh Nguyen Phuong, Frederic Fina, Romain Zakrajsek, Lucie Della-Negra, Pascale Tomasini, Jean-Laurent Deville, Laurent Greillier, Caroline Gaudy-Marqueste, Audrey Boutonnet, Frédéric Ginot, Jean-Charles Garcia, Sébastien Salas, Sébastien Benzekry
  https://inria.hal.science/hal-05241536v1
  
• Mechanistic modeling of tumor and size-dependent cell-free DNA kinetics under immune checkpoint inhibition
  2025
  Linh Nguyen Phuong, Frédéric Fina, Laurent Greillier, Pascale Tomasini, Jean-Laurent Deville, Audrey Boutonnet, Frédéric Ginot, Jean-Charles Garcia, Sebastien Salas, Sébastien Benzekry
  https://inria.hal.science/hal-05241421v1
  
• The Rechallenge Benefit Score: A Clinical Decision Tool for Patients Progressing After Immunotherapy
  2025
  Caroline Plazy, Mohamed Boussena, Linh Nguyen Phuong, Baptiste Assié Jean, Emmanuel Grolleau, Valerie Gounant, Nouha Chaabane, Chantal Decroisette, Eric Dansin, Hélène Babey, Catherine Daniel, Giroux Leprieur Etienne, David Planchard, Mariona Riuvadets, Anthony Canellas, Youssef Oulkhouir, Maurice Pérol, Anne-Claire Toffart, Sebastien Benzekry, Elisa Gobbini
  https://inria.hal.science/hal-05240613v1
  
• The SChISM study: Cell-free DNA size profiles as predictors of progression in advanced carcinoma treated with immune-checkpoint inhibitors
  2025
  Linh Nguyen Phuong, Frederic Fina, Laurent Greillier, Pascale Tomasini, Jean-Laurent Deville, Romain Zakrasjek, Lucie Della-Negra, Audrey Boutonnet, Frédéric Ginot, Jean-Charles Garcia, Sébastien Benzekry, Sébastien Salas
  https://inria.hal.science/hal-05238567v1
  
• Circulating cell-free DNA size distribution as a prediction marker for early progression undergoing immune checkpoint inhibitors
  2024
  Linh Nguyen Phuong, Frederic Fina, Laurent Greillier, Caroline Gaudy-Marqueste, Jean-Laurent Deville, Audrey Boutonnet, Frédéric Ginot, Sébastien Salas, Sébastien Benzekry
  https://hal.science/hal-04665025v1
  
• Integrating tumor kinetics and circulating cell-free DNA markers through mechanistic modeling for early prediction of immunotherapy response
  2024
  Linh Nguyen Phuong, Frederic Fina, Laurent Greillier, Caroline Gaudy-Marqueste, Jean-Laurent Deville, Jean-Charles Garcia, Sébastien Salas, Sébastien Benzekry
  https://hal.science/hal-04665038v1
  
• Long cell-free DNA fragments predict early-progression in patients with advanced or metastatic cancer treated with immune-checkpoint inhibition.
  2024
  Sébastien Salas, Linh Nguyen Phuong, Jean-Charles Garcia, Laurent Greillier, Caroline Gaudy-Marqueste, Jean-Laurent Deville, Audrey Boutonnet, Frédéric Ginot, Frédéric Fina, Sébastien Benzekry
  https://hal.science/hal-04717544v1
  
• Long circulating-free DNA fragments predict early-progression (EP) and progression-free-survival (PFS) in advanced carcinoma treated with immune-checkpoint inhibition (ICI): a new biomarker
  2024
  Sébastien Salas, Linh Nguyen Phuong, Frédéric Ginot, Laurent Greillier, Pascale Tomasini, Audrey Boutonnet, Jean-Laurent Deville, Frederic Fina, Sébastien Benzekry
  https://inria.hal.science/hal-04717549v1